Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-21

Clinical Trial Update: Rhythm Control and Potential Early Surgery for Tricuspid Regurgitation [NA]

View source ↗

Summary

This Mayo Clinic-sponsored trial evaluating rhythm control and potential early surgery for severe tricuspid regurgitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Severe Tricuspid Valve Regurgitation (Disorder) | NA | Status: COMPLETED